They absolutely achieved the BOD's OBJECTIVES to justify another round of trials.
You know to generate the data for BP's so they can negotiate the never ending deal they've been talking about for years.
But hey great news, they can run a few side trials on novel cancer treatments in the next round to further their knowledge on how to string us along after the next trials meet THEIR OBJECTIVES.
It's just a shame they'll have to keep paying themselves a few more years longer but at least they can grant themseleves some more options for all their hadwork on those complex time consuming board meetings (oops trial results).
The only OBJECTIVE I care about is the deal they PROMISED last time they induced long suffering shareholders to invest in this crap.
Lots wrong now.
Ann: Letter to Shareholders, page-94
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
